WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005016860) STILBENE DERIVATIVES AND THEIR USE IN MEDICAMENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/016860 International Application No.: PCT/AT2004/000279
Publication Date: 24.02.2005 International Filing Date: 09.08.2004
Chapter 2 Demand Filed: 14.03.2005
IPC:
C07C 43/215 (2006.01)
Applicants: SZEKERES, Thomas[AT/AT]; AT
HANDLER, Norbert[AT/AT]; AT (UsOnly)
JÄGER, Walter[AT/AT]; AT (UsOnly)
MURIAS, Arkadiusz, Marek[AT/AT]; AT (UsOnly)
ERKER, Thomas[AT/AT]; AT (UsOnly)
Inventors: SZEKERES, Thomas; AT
HANDLER, Norbert; AT
JÄGER, Walter; AT
MURIAS, Arkadiusz, Marek; AT
ERKER, Thomas; AT
Agent: BEER, Manfred ; Lindengasse 8 A-1070 Wien, AT
Priority Data:
A 1285/200314.08.2003AT
Title (EN) STILBENE DERIVATIVES AND THEIR USE IN MEDICAMENTS
(FR) DERIVES DE STILBENE, ET LEUR UTILISATION POUR PRODUIRE DES MEDICAMENTS
(DE) STILBEN-DERIVATE UND DEREN VERWENDUNG IN ARZNEIMITTELN
Abstract: front page image
(EN) The invention relates to stilbene derivatives of general formula (I), in which at least four of the substituents R1 to R6 do not represent hydrogen. The substituents are effective radical captors, anti-tumour active ingredients and selective cyclooxygenase-2 inhibitors.
(FR) L'invention concerne des dérivés de stilbène de formule générale (I) dans laquelle au moins quatre des substituents R1 à R6 ont une signification autre que hydrogène. Lesdits substituents sont de puissants capteurs de radicaux libres, agents antitumoraux et inhibiteurs sélectifs de la cyclo-oxygénase-2.
(DE) Beschrieben werden Stilbenderivate der alllgemeinen Formel (I); In dieser haben wenigstens vier der Substituenten R1 bis R6 eine andere Bedeutung als Wasserstoff. Die Substituenten sind wirksame Radikalfänger, Antitumorwirkstoffe und selektive Cyclooxygenase-2-Inhibitoren.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: German (DE)
Filing Language: German (DE)